Transgenomic's Q1 Revenues Increase 8 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic this week reported first-quarter revenue growth of 8 percent, with instrument sales up 12 percent year over year.

The Omaha, Neb.-based firm took in total revenues of $5.4 million for the three-month period ended March 31, compared to $5 million for the first quarter of 2009.

Transgenomic cut its net loss by nearly two-thirds to $324,000, or $.01 per share, from $953,000, or $.02 per share, for the first quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.